Category: Reformulary Group

CANNABIS STANDARD INDEX BRINGS MUCH-NEEDED CLARITY TO MEDICAL CANNABIS

TORONTO, September 3, 2020 – Reformulary Group is pleased to announce the launch of its Cannabis Standard™ Index. The Index uniformly categorizes medical cannabis products based on objective data, allowing Canadians and the medical community to find accurate, detailed information and to reliably search and compare products. MORE>>

REFORMULARY GROUP ANNOUNCES PREFERRED PHARMACY PARTNERSHIP WITH REXALL

Toronto, August 28, 2020 – Reformulary Group, an expert-led Canadian healthcare company, today announced its preferred pharmacy partnership with Rexall™, one of Canada’s largest and most trusted pharmacy organizations. MORE>>

CIX CANADIAN INNOVATION EXCHANGE ANNOUNCED REFORMULARY GROUP AS A CIX TOP 20 EARLY INNOVATIVE CANADIAN TECHNOLOGY START-UPS OF 2019

Toronto, Canada, Wednesday, September 4, 2019 – Today, CIX Canadian Innovation Exchange announced the CIX TOP 20 Early and CIX TOP 10 Growth innovative Canadian technology startups that have been inducted into the annual program. The selected companies represent a diverse range of tech including software, AI, medtech, fintech, big data, aerospace, security, Saas and cleantech. These game-changing, on-the-rise …

Continue reading

CANADA’S FIRST EVIDENCE-BASED MEDICAL CANNABIS FORMULARY LAUNCHES TODAY

TORONTO, March 20, 2019 (GLOBE NEWSWIRE) — Reformulary Group, a Canadian healthcare technology company, today announced the launch of Cannabis Standard™ – the first evidence-based medical cannabis formulary and research platform for patients, employers and physicians – available on a subscription basis to patients. Cannabis Standard, one-part formulary and one-part research platform, uses evidence to help …

Continue reading

REFORMULARY GROUP SIGNS APHRIA TO PROVIDE MEDICAL CANNABIS FOR EMPLOYER PLANS

TORONTO, May 29, 2018 (GLOBE NEWSWIRE) — Reformulary Group, Canada’s leading, independent drug plan management company, today announced it has signed Leamington, Ontario-based cannabis producer Aphria Inc. as its second Licensed Producer of medical cannabis for employer plans. MORE>>